According to the latest data from the Hong Kong Stock Exchange, on August 26, GL Capital Management GP Limited reduced its holdings in LEE'S PHARM (00950) by 2.942 million shares at HK$1.8776 per share, with a total transaction value of approximately HK$5.5239 million. After the reduction, the latest shareholding stands at approximately 39.0995 million shares, representing a 6.64% stake. The transaction involves other related parties: Assicurazioni Generali SpA, Li Zhenfu, and Lion River I N.V.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.